Efficacy and safety of a new intravenous immunoglobulin (Panzyga^® ) in chronic immune thrombocytopenia.

Most importantly, a highly significant increase in platelet count was observed mostly within 24 h after the first dose (Fig. 1 ), i.e. on day 2 [from 8·8 × 10 9 L −1 (±5·76) to 41·6 × 10 9 L −1 (±31·41); P < 0·0001].

also in 132,142 other papers